- Home
- KALA vs WKSP Comparison
KALA vs WKSP Comparison
Compare KALA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- WKSP
- Stock Information
- Founded
- KALA 2009
- WKSP 2003
- Country
- KALA United States
- WKSP United States
- Employees
- KALA N/A
- WKSP N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- KALA Health Care
- WKSP Consumer Discretionary
- Exchange
- KALA Nasdaq
- WKSP Nasdaq
- Market Cap
- KALA 27.3M
- WKSP 27.2M
- IPO Year
- KALA 2017
- WKSP N/A
- Fundamental
- Price
- KALA $7.69
- WKSP $0.96
- Analyst Decision
- KALA Strong Buy
- WKSP Strong Buy
- Analyst Count
- KALA 2
- WKSP 1
- Target Price
- KALA $15.00
- WKSP $2.00
- AVG Volume (30 Days)
- KALA 47.7K
- WKSP 1.5M
- Earning Date
- KALA 11-12-2024
- WKSP 11-13-2024
- Dividend Yield
- KALA N/A
- WKSP N/A
- EPS Growth
- KALA N/A
- WKSP N/A
- EPS
- KALA N/A
- WKSP N/A
- Revenue
- KALA N/A
- WKSP $6,395,908.00
- Revenue This Year
- KALA N/A
- WKSP $424.11
- Revenue Next Year
- KALA N/A
- WKSP $260.82
- P/E Ratio
- KALA N/A
- WKSP N/A
- Revenue Growth
- KALA N/A
- WKSP 776.97
- 52 Week Low
- KALA $4.21
- WKSP $0.36
- 52 Week High
- KALA $8.79
- WKSP $1.54
- Technical
- Relative Strength Index (RSI)
- KALA 61.19
- WKSP 58.18
- Support Level
- KALA $7.00
- WKSP $0.76
- Resistance Level
- KALA $8.79
- WKSP $0.88
- Average True Range (ATR)
- KALA 0.61
- WKSP 0.11
- MACD
- KALA 0.05
- WKSP -0.01
- Stochastic Oscillator
- KALA 51.97
- WKSP 46.07
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.